Home › Companies › CERVOMED INC. › 2024-2025
At CERVOMED INC.'s shareholder meeting held June 23, 2025, in the 2024-2025 proxy season, 66 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 605 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers… — FOR was 99.1% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CERVOMED INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 25, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CERVOMED INC.’s Form 8-K, filed June 25, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 23, 2025: 10 items on CERVOMED INC.’s Form 8-K, filed June 25, 2025: 10 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025
Explore CERVOMED INC. in the interactive database Compare manager voting policies
These tallies are CERVOMED INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 25, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: John Alam, M.D. | 3,923,241 | -- | -- | 21,554 | 1,665,442 | 99.4% | Not verified | — |
| Elect Director: Joshua S. Boger, Ph.D. | 3,928,919 | -- | -- | 15,876 | 1,665,442 | 99.5% | Not verified | — |
| Elect Director: Sylvie Grégoire, PharmD. | 3,924,920 | -- | -- | 19,875 | 1,665,442 | 99.4% | Not verified | — |
| Elect Director: Jane H. Hollingsworth, J.D. | 3,840,585 | -- | -- | 104,210 | 1,665,442 | 97% | Not verified | — |
| Elect Director: Jeff Poulton | 3,910,346 | -- | -- | 34,449 | 1,665,442 | 99.1% | Not verified | — |
| Elect Director: Marwan Sabbagh, M.D. | 3,928,461 | -- | -- | 16,334 | 1,665,442 | 99.5% | Not verified | — |
| Elect Director: Frank Zavrl | 3,909,962 | -- | -- | 34,833 | 1,665,442 | 99.1% | Not verified | — |
| 2. To ratify the selection of RSM US LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 | 5,571,505 | 25,008 | 13,724 | -- | -- | 99.5% | Not verified | a majority of the shares present or represented |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers during the year ended December 31, 2024, as disclosed in the Proxy Statement | 3,891,229 | 33,195 | 20,371 | -- | 1,665,442 | 99.1% | Not verified | a majority of the shares present or represented |
| 4. To approve the CervoMed Inc. 2025 Equity Incentive Plan | 3,798,568 | 137,758 | 8,469 | -- | 1,665,442 | 97% | Not verified | a majority of the shares present or represented |
Source: CERVOMED INC., Form 8-K, filed with the SEC on June 25, 2025 — read the filing on EDGAR.
Each item below shows how the 66 asset managers that disclosed a CERVOMED INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Frank Zavrl
CERVOMED INC.’s own tally for this item (“Elect Director: Frank Zavrl”): 3,909,962 for, 34,833 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 135,864 for, 4,154 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 3,348 | Withhold |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 763 | Withhold |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 529 | 0 | 0 | 0 | For |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 43 | Withhold |
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jane H. Hollingsworth, J.D.
CERVOMED INC.’s own tally for this item (“Elect Director: Jane H. Hollingsworth, J.D.”): 3,840,585 for, 104,210 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 131,412 for, 8,606 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 3,348 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 2,829 | Withhold |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 985 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 763 | Withhold |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 529 | Withhold |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 59 | Withhold |
| Guggenheim | 0 | 0 | 0 | 50 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 43 | Withhold |
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeff Poulton
CERVOMED INC.’s own tally for this item (“Elect Director: Jeff Poulton”): 3,910,346 for, 34,449 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 134,567 for, 5,451 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 3,348 | Withhold |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 1,087 | 0 | 0 | 1,340 | Mixed |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 763 | Withhold |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 529 | 0 | 0 | 0 | For |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 43 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: John Alam, MD.
CERVOMED INC.’s own tally for this item (“Elect Director: John Alam, M.D.”): 3,923,241 for, 21,554 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 140,018 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 3,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 529 | 0 | 0 | 0 | For |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 43 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Joshua S. Boger, Ph.D.
CERVOMED INC.’s own tally for this item (“Elect Director: Joshua S. Boger, Ph.D.”): 3,928,919 for, 15,876 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 139,489 for, 529 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 3,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 529 | Withhold |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 43 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Marwan Sabbagh, MD.
CERVOMED INC.’s own tally for this item (“Elect Director: Marwan Sabbagh, M.D.”): 3,928,461 for, 16,334 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 139,975 for, 43 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 3,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 529 | 0 | 0 | 0 | For |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 43 | Withhold |
Combines 4 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Sylvie Gregoire, PharmD.
CERVOMED INC.’s own tally for this item (“Elect Director: Sylvie Grégoire, PharmD.”): 3,924,920 for, 19,875 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 140,018 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 3,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 529 | 0 | 0 | 0 | For |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 43 | 0 | 0 | 0 | For |
97% Majority: yes · of votes cast
Description as filed by funds: To approve the CervoMed Inc. 2025 Equity Incentive Plan.
CERVOMED INC.’s own tally for this item (“4. Proposal No. 4 – To approve the CervoMed Inc. 2025 Equity Incentive Plan”): 3,798,568 for, 137,758 against, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the shares present or represented (“majority of the votes present”).
The 24 asset managers below reported 128,511 for, 11,507 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 0 | 5,905 | 0 | 0 | Against |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 3,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 2,829 | 0 | 0 | Against |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 0 | 985 | 0 | 0 | Against |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 704 | 0 | 0 | Against |
| Calvert | 0 | 529 | 0 | 0 | Against |
| T. Rowe Price | 0 | 403 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 0 | 59 | 0 | 0 | Against |
| Guggenheim | 0 | 50 | 0 | 0 | Against |
| Goldman Sachs | 0 | 43 | 0 | 0 | Against |
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers during the year ended December 31, 2024, as disclosed in the accompanying proxy statement.
CERVOMED INC.’s own tally for this item (“3. Proposal No. 3 – To approve, on an advisory basis, the compensation of the Company's named executive officers during the year ended December 31, 2024, as disclosed in the Proxy Statement”): 3,891,229 for, 33,195 against, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the shares present or represented (“majority of the votes present”).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 3,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 529 | 0 | 0 | 0 | For |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 43 | 0 | 0 | Against |
Fund voting reports, all 24 managers: 139,975 for, 43 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 70,743 | 0 | 0 | 0 | For |
| Northern Trust | 46,764 | 0 | 0 | 0 | For |
| BlackRock | 40,770 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 23,878 | 0 | 0 | 0 | For |
| AQR | 21,602 | 0 | 0 | 0 | For |
| Nuveen | 11,129 | 0 | 0 | 0 | For |
| Fidelity | 10,086 | 0 | 0 | 0 | For |
| Vanguard | 9,822 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 9,346 | 0 | 0 | 0 | For |
| JPMorgan | 2,444 | 0 | 0 | 0 | For |
| Invesco | 2,367 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 1,915 | 0 | 0 | Against |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 1,800 | 0 | 0 | Against |
| SCOTIA CAPITAL INC. | 1,700 | 0 | 0 | 0 | For |
| Rhumbline | 1,643 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,340 | 0 | 0 | 0 | For |
| SEI | 1,327 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 1,197 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,063 | 0 | 0 | 0 | For |
| Clarkston Capital Partners, LLC | 1,000 | 0 | 0 | 0 | For |
| Atom Investors LP | 931 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 925 | 0 | 0 | 0 | For |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 704 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 700 | 0 | 0 | 0 | For |
Institutional-manager reports, all 51 managers: 266,577 for, 4,996 against. Showing the 25 largest; every one is in the interactive database (link above).
99.5% Majority: yes · of votes cast
Description as filed by funds: To ratify the selection of RSM US LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.
CERVOMED INC.’s own tally for this item (“2. Proposal No. 2 – To ratify the selection of RSM US LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 5,571,505 for, 25,008 against, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the shares present or represented (“majority of the votes present”).
The 24 asset managers below reported 140,018 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,045 | 0 | 0 | 0 | For |
| BlackRock | 32,735 | 0 | 0 | 0 | For |
| Fidelity | 23,430 | 0 | 0 | 0 | For |
| Northern Trust | 7,912 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 6,865 | 0 | 0 | 0 | For |
| TIAA | 5,905 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 0 | 0 | 0 | For |
| Global X | 3,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,829 | 0 | 0 | 0 | For |
| Equitable | 2,427 | 0 | 0 | 0 | For |
| State Street | 2,122 | 0 | 0 | 0 | For |
| Pacific Life | 1,907 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,052 | 0 | 0 | 0 | For |
| ProShares | 985 | 0 | 0 | 0 | For |
| Charles Schwab | 763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 704 | 0 | 0 | 0 | For |
| Calvert | 529 | 0 | 0 | 0 | For |
| T. Rowe Price | 403 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 303 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 200 | 0 | 0 | 0 | For |
| Nationwide | 102 | 0 | 0 | 0 | For |
| DWS | 59 | 0 | 0 | 0 | For |
| Guggenheim | 50 | 0 | 0 | 0 | For |
| Goldman Sachs | 43 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 8,702,719 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 0.47% |
| 2 | BlackRock | 0.38% |
| 3 | Fidelity | 0.27% |
| 4 | Northern Trust | 0.09% |
| 5 | QUANTITATIVE MASTER SERIES LLC | 0.08% |
| 6 | TIAA | 0.07% |
| 7 | Lincoln Financial | 0.05% |
| 8 | Global X | 0.04% |
| 9 | AIG/SunAmerica | 0.03% |
| 10 | Equitable | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 0.81% |
| 2 | Northern Trust | 0.54% |
| 3 | BlackRock | 0.47% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.27% |
| 5 | AQR | 0.25% |
| 6 | Nuveen | 0.13% |
| 7 | Fidelity | 0.12% |
| 8 | Vanguard | 0.11% |
| 9 | MELLON INVESTMENTS Corp | 0.11% |
| 10 | JPMorgan | 0.03% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BOGER JOSHUA S | — | 13D |
| John Alam, M.D., President, Chief Executive Officer & Director | — | DEF14A |
| Sylvie Grégoire, PharmD., Director | — | DEF14A |
| Joshua S. Boger, Ph.D., Chair of the Board | — | DEF14A |
| RA Capital Management, L.P. | — | 13G |
| CVI Investments, Inc. | — | 13G |
| Armistice Capital Master Fund L.P. | — | DEF14A |
| AWM Investment Company, Inc. | — | 13G |
| Vanguard Group | — | 13F |
| Frank Zavrl, Director | — | DEF14A |
Percentages above are of 8,702,719 shares outstanding, as reported by CERVOMED INC. on its Form 10-Q dated May 9, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CERVOMED INC.’s 10-Q dated May 9, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
CERVOMED INC. proxy season coverage: 2024-2025 (this page).
proxyvotesnow.com, “CERVOMED (CRVO) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/cervomed-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.